BCL2L1
BCL2L1 (BCL2 like 1, also called Bcl-X, BCLX or bcl-xL) is a member of the Bcl-2 protein family that regulates apoptosis. Alternative splicing gives two isoforms with opposing roles: a longer one that inhibits apoptosis and a shorter one that promotes it. Browse Assay Genie's current range of BCL2L1 research reagents below, or read on for the biology behind the target.
BCL2L1 encodes Bcl-2-like protein 1, a member of the Bcl-2 family. Members of this family form hetero- or homodimers and act as anti- or pro-apoptotic regulators involved in a wide variety of cellular activities. The BCL2L1 gene products are located at the outer mitochondrial membrane, where they have been shown to regulate opening of the outer mitochondrial membrane channel, VDAC.
VDAC regulates mitochondrial membrane potential, and so controls the production of reactive oxygen species and the release of cytochrome C by mitochondria. Both are potent inducers of apoptosis, which places the BCL2L1 protein at a control point in the mitochondrial cell death pathway.
Alternative splicing produces multiple transcript variants that encode two different isoforms. The longer isoform, Bcl-xL, acts as an apoptotic inhibitor, while the shorter isoform, Bcl-xS, acts as an apoptotic activator and promotes apoptosis. The same gene can therefore push a cell towards survival or death depending on which isoform is produced.
UniProt lists the protein in several compartments: the inner and outer mitochondrial membranes, the mitochondrial matrix, the cytosol, the centrosome, the nuclear membrane and synaptic vesicle membranes. The gene is also known as BCL2L, PPP1R52 and Bcl-X, and HGNC places it in both the BCL2 family and the protein phosphatase 1 regulatory subunit group.
BCL2L1 isoforms inhibit or promote apoptosis, making the gene a useful system for studying how Bcl-2 family balance sets cell fate.
The protein regulates VDAC opening at the outer mitochondrial membrane, linking it to membrane potential, reactive oxygen species and cytochrome C release.
One gene yields a longer anti-apoptotic isoform and a shorter pro-apoptotic isoform, offering a clear model of splicing-dependent functional switching.
BCL2L1 forms hetero- and homodimers with other family members, so it is studied alongside related regulators to map pro- and anti-apoptotic interactions.
BCL2L1 is a Bcl-2 family regulator of apoptosis. Its products sit at the outer mitochondrial membrane and regulate VDAC opening, which influences membrane potential, reactive oxygen species production and cytochrome C release. The longer isoform inhibits apoptosis, whereas the shorter Bcl-X(S) isoform promotes it.
BCL2L1 is also known as BCLX, BCL2L, Bcl-X and PPP1R52. Alternative splicing gives two isoforms: the longer bcl-xL, an apoptotic inhibitor, and the shorter bcl-xS, an apoptotic activator. Check the datasheet of any product for the isoforms it recognises.
Yes. Mouse and rat both have an ortholog named Bcl2l1, so the gene can be studied in common rodent models. Check the datasheet of any product for its validated reactivity before choosing a reagent for a given species.
Other Bcl-2 family members and BCL-named regulators with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q07817; product specifications from Assay Genie datasheets.